Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FTSE 100 ends flat in run-up to Fed verdict; UK inflation softens

Published 20/03/2024, 08:44
Updated 20/03/2024, 17:40
© Reuters. Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/file photo

By Shristi Achar A, Pranav Kashyap and Johann M Cherian

(Reuters) -London's FTSE 100 closed flat on Wednesday with caution looming ahead of the U.S. Federal Reserve's policy decision, while softer domestic inflation data cemented bets of interest rate cuts this year from the Bank of England.

The globally-focussed FTSE 100 held its ground at 7,737.38 points with traders gearing up for the Fed's monetary policy decision at 1800 GMT and remarks on the timing of interest rate cuts.

Closer to home, Britain's inflation cooled to 3.4% in February ahead of the Bank of England's monetary policy verdict on Thursday and offering some respite to Prime Minister Rishi Sunak before an election expected later this year.

Rate sensitive sectors such as banks and gained 0.6% and 1.1% respectively.

Traders now see about 70 basis points of rate cuts by the BoE this year, up from around 67 bps prior to the data release. [0#BOEWATCH]

"While the Bank of England will also cheer the decline in the headline figure, it is unlikely to be convinced that the battle against inflation is won," said Zara Nokes, global market analyst at J.P. Morgan Asset Management.

"The Bank will instead be keeping a watchful eye on the medium-term inflation outlook, particularly the domestically-generated inflation originating from the services sector."

So far this year, UK stocks have underperformed developed economy peers, given a stagnating economy and uncertainty on the timeline for interest rate cuts.

On the day, the domestically focused FTSE 250 added 0.3%, with Johnson Matthey (LON:JMAT) gaining 7.8% to hit a 10-month high following the chemicals maker's announcement that it will sell its medical device components business to Montagu Private Equity for $700 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The broader chemicals sector (FTNMX552010) advanced 3.4%.

Among others, Burberry fell 3.3%, tracking a fall in European luxury goods group Kering (LON:0IIH), which warned about a potential sales drop in the first quarter.

The stock dragged the personal goods index by 3.7% to an over 11-year low.

Halma (LON:HLMA) Plc rose 3.9%, among top FTSE 100 performers, after UBS upgraded the technology firm to "buy" from "neutral".

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.